Literature DB >> 9374484

Protein kinase C-zeta as a downstream effector of phosphatidylinositol 3-kinase during insulin stimulation in rat adipocytes. Potential role in glucose transport.

M L Standaert1, L Galloway, P Karnam, G Bandyopadhyay, J Moscat, R V Farese.   

Abstract

Insulin provoked rapid increases in enzyme activity of immunoprecipitable protein kinase C-zeta (PKC-zeta) in rat adipocytes. Concomitantly, insulin provoked increases in 32P labeling of PKC-zeta both in intact adipocytes and during in vitro assay of immunoprecipitated PKC-zeta; the latter probably reflected autophosphorylation, as it was inhibited by the PKC-zeta pseudosubstrate. Insulin-induced activation of immunoprecipitable PKC-zeta was inhibited by LY294002 and wortmannin; this suggested dependence upon phosphatidylinositol (PI) 3-kinase. Accordingly, activation of PI 3-kinase by a pYXXM-containing peptide in vitro resulted in a wortmannin-inhibitable increase in immunoprecipitable PKC-zeta enzyme activity. Also, PI-3,4-(PO4)2, PI-3,4,5-(PO4)3, and PI-4,5-(PO4)2 directly stimulated enzyme activity and autophosphoralytion in control PKC-zeta immunoprecipitates to levels observed in insulin-treated PKC-zeta immunoprecipitates. In studies of glucose transport, inhibition of immunoprecipitated PKC-zeta enzyme activity in vitro by both the PKC-zeta pseudosubstrate and RO 31-8220 correlated well with inhibition of insulin-stimulated glucose transport in intact adipocytes. Also, in adipocytes transiently expressing hemagglutinin antigen-tagged GLUT4, co-transfection of wild-type or constitutive PKC-zeta stimulated hemagglutinin antigen-GLUT4 translocation, whereas dominant-negative PKC-zeta partially inhibited it. Our findings suggest that insulin activates PKC-zeta through PI 3-kinase, and PKC-zeta may act as a downstream effector of PI 3-kinase and contribute to the activation of GLUT4 translocation.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9374484     DOI: 10.1074/jbc.272.48.30075

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  100 in total

1.  Closing in on the cause of insulin resistance and type 2 diabetes.

Authors:  M J Brady; A R Saltiel
Journal:  J Clin Invest       Date:  1999-09       Impact factor: 14.808

2.  Ca(2+)-evoked serotonin secretion by parafollicular cells: roles in signal transduction of phosphatidylinositol 3'-kinase, and the gamma and zeta isoforms of protein kinase C.

Authors:  K Liu; S Hsiung; M Adlersberg; T Sacktor; M D Gershon; H Tamir
Journal:  J Neurosci       Date:  2000-02-15       Impact factor: 6.167

3.  Expression of a prenylation-deficient Rab4 inhibits the GLUT4 translocation induced by active phosphatidylinositol 3-kinase and protein kinase B.

Authors:  M Cormont; N Gautier; K Ilc; Y le Marchand-Brustel
Journal:  Biochem J       Date:  2001-05-15       Impact factor: 3.857

4.  Insulin-induced GLUT4 translocation involves protein kinase C-lambda-mediated functional coupling between Rab4 and the motor protein kinesin.

Authors:  Takeshi Imamura; Jie Huang; Isao Usui; Hiroaki Satoh; Jennie Bever; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2003-07       Impact factor: 4.272

5.  Effect of SNPs in protein kinase C zeta gene on gene expression in the reporter gene detection system.

Authors:  Zhuo Liu; Hong-Xia Sun; Yong-Wei Zhang; Yun-Feng Li; Jin Zuo; Yan Meng; Fu-De Fang
Journal:  World J Gastroenterol       Date:  2004-08-15       Impact factor: 5.742

6.  Protein phosphatase 2A negatively regulates insulin's metabolic signaling pathway by inhibiting Akt (protein kinase B) activity in 3T3-L1 adipocytes.

Authors:  Satoshi Ugi; Takeshi Imamura; Hiroshi Maegawa; Katsuya Egawa; Takeshi Yoshizaki; Kun Shi; Toshiyuki Obata; Yousuke Ebina; Atsunori Kashiwagi; Jerrold M Olefsky
Journal:  Mol Cell Biol       Date:  2004-10       Impact factor: 4.272

7.  Insulin signalling in hepatocytes of humans with type 2 diabetes: excessive production and activity of protein kinase C-ι (PKC-ι) and dependent processes and reversal by PKC-ι inhibitors.

Authors:  M P Sajan; R V Farese
Journal:  Diabetologia       Date:  2012-02-15       Impact factor: 10.122

8.  Fibroblast growth factor-19, a novel factor that inhibits hepatic fatty acid synthesis.

Authors:  Sushant Bhatnagar; Holly A Damron; F Bradley Hillgartner
Journal:  J Biol Chem       Date:  2009-02-20       Impact factor: 5.157

9.  Protein kinase C/zeta (PRKCZ) gene is associated with type 2 diabetes in Han population of North China and analysis of its haplotypes.

Authors:  Yun-Feng Li; Hong-Xia Sun; Guo-Dong Wu; Wei-Nan Du; Jin Zuo; Yan Shen; Bo-Qin Qiang; Zhi-Jian Yao; Heng Wang; Wei Huang; Zhu Chen; Mo-Miao Xiong; Yan Meng; Fu-De Fang
Journal:  World J Gastroenterol       Date:  2003-09       Impact factor: 5.742

10.  Activation of protein kinase C zeta induces serine phosphorylation of VAMP2 in the GLUT4 compartment and increases glucose transport in skeletal muscle.

Authors:  L Braiman; A Alt; T Kuroki; M Ohba; A Bak; T Tennenbaum; S R Sampson
Journal:  Mol Cell Biol       Date:  2001-11       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.